IL1B and breast cancer: Therefore, we speculate that inhibiting downstream targets of IL-1 (IRAK1, TRAF6, IKK) has effects on reducing osteoclastic bone resorption, while IL1β inhibition not only reduces osteoclastic bone resorption but also blocks breast cancer metastasis to bone.